171 related articles for article (PubMed ID: 16380476)
1. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.
Endl J; Rosinger S; Schwarz B; Friedrich SO; Rothe G; Karges W; Schlosser M; Eiermann T; Schendel DJ; Boehm BO
Diabetes; 2006 Jan; 55(1):50-60. PubMed ID: 16380476
[TBL] [Abstract][Full Text] [Related]
2. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis.
Wilde B; Dolff S; Cai X; Specker C; Becker J; Tötsch M; Costabel U; Dürig J; Kribben A; Tervaert JW; Schmid KW; Witzke O
Nephrol Dial Transplant; 2009 Jan; 24(1):161-71. PubMed ID: 18723571
[TBL] [Abstract][Full Text] [Related]
4. Autoreactive T cell response in CD25-negative fraction of peripheral blood mononuclear cells in established type 1 diabetes.
Moriyama H; Kotani R; Katsuta A; Kameno M; Arai T; Okumachi Y; Kishi M; Yamada K; Yasuda H; Hara K; Yokono K; Nagata M
Ann N Y Acad Sci; 2008 Dec; 1150():278-81. PubMed ID: 19120313
[TBL] [Abstract][Full Text] [Related]
5. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease.
Weinberg AD
Mol Med Today; 1998 Feb; 4(2):76-83. PubMed ID: 9547794
[TBL] [Abstract][Full Text] [Related]
7. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
[TBL] [Abstract][Full Text] [Related]
8. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
[TBL] [Abstract][Full Text] [Related]
9. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
10. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
Glinka Y; Chang Y; Prud'homme GJ
Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
[TBL] [Abstract][Full Text] [Related]
11. Persistent T cell anergy in human type 1 diabetes.
Dosch H; Cheung RK; Karges W; Pietropaolo M; Becker DJ
J Immunol; 1999 Dec; 163(12):6933-40. PubMed ID: 10586096
[TBL] [Abstract][Full Text] [Related]
12. Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134.
Nolte-'t Hoen EN; Boot EP; Wagenaar-Hilbers JP; van Bilsen JH; Arkesteijn GJ; Storm G; Everse LA; van Eden W; Wauben MH
J Leukoc Biol; 2008 Jan; 83(1):112-21. PubMed ID: 17928458
[TBL] [Abstract][Full Text] [Related]
13. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
[TBL] [Abstract][Full Text] [Related]
14. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40).
Pippig SD; Peña-Rossi C; Long J; Godfrey WR; Fowell DJ; Reiner SL; Birkeland ML; Locksley RM; Barclay AN; Killeen N
J Immunol; 1999 Dec; 163(12):6520-9. PubMed ID: 10586044
[TBL] [Abstract][Full Text] [Related]
15. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
[TBL] [Abstract][Full Text] [Related]
16. Autoreactive T cells in endocrine/organ-specific autoimmunity: why has progress been so slow?
Roep BO
Springer Semin Immunopathol; 2002 Dec; 24(3):261-71. PubMed ID: 12503054
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.
Harnaha J; Machen J; Wright M; Lakomy R; Styche A; Trucco M; Makaroun S; Giannoukakis N
Diabetes; 2006 Jan; 55(1):158-70. PubMed ID: 16380489
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of OX40 expressed on human CD8+ T cells.
Fujita T; Ukyo N; Hori T; Uchiyama T
Immunol Lett; 2006 Jul; 106(1):27-33. PubMed ID: 16750861
[TBL] [Abstract][Full Text] [Related]
19. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
[TBL] [Abstract][Full Text] [Related]
20. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
